Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2001

View Archived Issues

Investigational immunotherapy for Alzheimer's disease enters phase IIa

Diversa and IntraBiotics discontinue antimicrobial alliance

Cell Matrix awarded grants for development of novel antiangiogenesis products

Adaptive Screening offers new approach to drug discovery

Second-quarter development progress reported by Sepracor

JNK inhibitor appears to have disease-modifying activity in rheumatoid arthritis

Role of dipeptidyl-peptidase IV in GIP metabolism, biological activity

FDA advisory committee to review IntraDose

Corvas provides status report for rNAPc2

Pilot studies suggest that EPA may be a novel therapeutic option in schizophrenia

Neurocrine Biosciences and GSK establish collaboration for CRF receptor antagonists

QLT and Novartis Ophthalmics expand verteporfin codevelopment agreement

Methotrexate-albumin conjugate may be particularly useful against prostate cancer, sarcomas

ProChon and MorphoSys identify new class of antibody

Chlamydia candidate vaccine reveals potential to protect against STD-related infertility

Inhibitors of HIV fusion and entry a focus of interest at recent conference

Abgenix and CuraGen make progress in development of novel antibody drug targets

Survival prolonged in tumor-bearing mice treated with GTI-2040

Lovastatin reduces coronary event risk in subjects with elevated C-reactive protein levels

Use of BTK inhibitor LFM-A13 for inhibiting platelet aggregation

New antitumor compounds in development at Pharmacia

Abbott claims ketolide antibacterial agents in recent patent

Preparation of dihydroquinoline derivatives and use as analgesics

Heterocyclic compounds from Takeda may have therapeutic potential in diabetic neuropathy

Antifungal chromone derivatives reported by Toyama

Kyorin's new PPAR activators reportedly useful in diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...